Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 37.36 [1] Core Insights - The company achieved a revenue of CNY 3.001 billion in 2025, representing a year-on-year increase of 16.7%, and a net profit attributable to shareholders of CNY 318 million, up 39.0%, which aligns with expectations [6] - The company continues to show strong fundamentals with a same-store sales growth of 6.9% and a robust cash flow of CNY 2.59 billion, reflecting a year-on-year increase of 41.6% [6] - The company is positioned as a leader in the beauty and health chain service sector, benefiting from a dual growth strategy of organic growth and acquisitions [6] Financial Performance - Revenue projections for 2026 and 2027 have been revised upwards to CNY 3.915 billion and CNY 4.315 billion, respectively, reflecting increases of 30.49% and 10.21% [10] - The net profit forecast for 2026 and 2027 has also been adjusted to CNY 415.26 million and CNY 533.94 million, indicating growth rates of 30.76% and 28.58% [10] - The company’s gross margin improved to 49.1% in 2025, up 2.8 percentage points year-on-year, driven by cost optimization and acquisitions [8] Business Segments - The beauty and wellness services segment generated revenue of CNY 1.658 billion in 2025, with a year-on-year growth of 14.9% [7] - The medical beauty services segment reported revenue of CNY 1.017 billion, reflecting a year-on-year increase of 9.6% [7] - The sub-health medical services segment saw significant growth, achieving revenue of CNY 326 million, up 62.2% year-on-year [7] Valuation Metrics - The company is projected to have a PE ratio of 19 times for 2026, reflecting its leading position in the beauty chain sector [10] - The expected dividend yield for 2026 is 4.41%, indicating a commitment to returning value to shareholders [5]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 37.36 [1]. Core Insights - The company achieved a revenue of CNY 3.001 billion in 2025, representing a year-on-year increase of 16.7%, and a net profit attributable to shareholders of CNY 318 million, up 39.0%, which aligns with expectations [6]. - The company continues to show strong fundamentals, with same-store sales growth of 6.9% and a high dividend payout ratio, with a year-end dividend of HKD 0.72 per share [6]. - The company is positioned as a leader in the beauty and health chain service sector, benefiting from a "dual beauty + dual healthcare" strategy, and is expected to leverage high-end consumption recovery trends for mid-term growth [6][10]. Financial Performance - Revenue projections for 2026 and 2027 have been revised upwards to CNY 39.15 billion and CNY 43.15 billion, respectively, reflecting increases of 18.6% and 21.5% [10]. - The company’s gross margin improved to 49.1% in 2025, up 2.8 percentage points year-on-year, driven by cost optimization and acquisitions [8]. - Operating cash flow for 2025 reached CNY 1.0 billion, marking a 25.4% increase year-on-year, demonstrating strong cash generation capabilities [9]. Business Segments - The beauty and wellness services segment generated revenue of CNY 1.658 billion in 2025, up 14.9%, with direct and franchise income growing by 15.8% and 5.9%, respectively [7]. - The medical beauty services segment reported revenue of CNY 1.017 billion, a year-on-year increase of 9.6%, with significant growth in customer traffic and average spending [7]. - The sub-health medical services segment saw remarkable growth, achieving revenue of CNY 326 million, up 62.2%, contributing to 10.9% of total revenue [7]. Valuation Metrics - The company’s projected PE ratio for 2026 is set at 19 times, reflecting its leading position in the beauty chain sector and expected growth from both organic and acquisition strategies [10]. - The report indicates a projected EPS of CNY 1.76 for 2026, with a continued focus on enhancing profitability through operational efficiencies [10].

Investment Rating - The report gives a "Buy" rating for the company based on its business layout and growth potential [6] Core Insights - The company, Meili Tianyuan, is a leader in the beauty and health sector, leveraging a "Double Beauty + Double Health" model to create a value closed loop and drive long-term growth through both organic and external expansion [3][5] - The beauty industry in China has significant growth potential, with Meili Tianyuan holding a prominent market position, particularly in the traditional beauty and non-surgical medical beauty segments [4][38] Company Overview - Meili Tianyuan has established itself as a leading player in the beauty and health management sector, focusing on high-end clientele and offering a comprehensive service system [10] - The company operates under multiple brands, including Meili Tianyuan, Beili Shi, Xiuker, and others, and has made strategic acquisitions to enhance its market presence [3][10] Beauty Industry - The traditional beauty market in China is projected to grow from CNY 403.2 billion in 2021 to CNY 640.2 billion by 2030, with a CAGR of 5.3% [4][38] - The non-surgical medical beauty market is expected to expand significantly, with a projected CAGR of 17.46% from CNY 97.7 billion in 2021 to CNY 415.7 billion by 2030 [4][48] Financial Analysis - The company's revenue grew from CNY 1.405 billion in 2019 to CNY 1.781 billion in 2021, with a net profit increase from CNY 147 million to CNY 208 million during the same period [3][20] - The revenue forecast for 2025-2027 is CNY 30.11 billion, CNY 40.16 billion, and CNY 45.63 billion, respectively, with net profits projected at CNY 3.36 billion, CNY 4.51 billion, and CNY 5.37 billion [6][20] Core Highlights - The "Double Beauty + Double Health" model effectively addresses customer needs and enhances loyalty through a complete service cycle, from acquisition to retention [5][64] - The company has a strong focus on digital operations and refined membership management to expand its customer base and drive steady growth across its business lines [5][64]

Core Insights - The company reported a revenue of 1.46 billion RMB for the first half of 2025, representing a year-on-year growth of 28.2% [1][2] - The growth is attributed to structural changes in the Chinese consumer healthcare market, with emotional value becoming a key factor in consumer decision-making [1][6] - The company's "Double Beauty + Double Health" business model has shown strong adaptability, with a significant increase in demand for health services among female consumers [1][4] Financial Performance - The net profit for the first half of 2025 reached 170 million RMB, up 35.5% year-on-year, with an adjusted net profit margin of 13.1%, a historical high [2][4] - Cash and cash-equivalent assets amounted to 2 billion RMB, reflecting a 27.5% increase, while operating cash flow surged by 84.4% to 410 million RMB [2][4] - The gross profit for the period was 720 million RMB, a 34.7% increase, with a gross margin of 49.3%, up 2.3 percentage points [4][5] Business Segments - The beauty and health services segment generated 810 million RMB in revenue, a 29.6% increase, with a gross margin of 42.1% [4][5] - Medical beauty services revenue rose to 500 million RMB, a 13.0% increase, with a gross margin of 56.9% [5] - The sub-health medical services brand, Yan Yuan Medical, saw revenue soar by 107.8% to 150 million RMB, marking its first time exceeding 10% of total revenue [5][7] Consumer Trends - Emotional value is increasingly influencing the consumption decisions of younger generations, with the emotional economy projected to reach 2.3 trillion RMB by 2025 [1][6] - The target demographic includes women in high-tier cities, who are increasingly focused on self-care and emotional well-being [6][7] - The average spending per visit for members was 1,086 RMB, with high-end beauty services averaging 1,166 RMB per visit, indicating strong consumer willingness to invest in self-care [6][7]

Core Viewpoint - Meili Tianyuan Medical Health Industry Co., Ltd. reported a strong performance for the first half of 2025, with revenue of 1.46 billion yuan, a year-on-year increase of 28.2%, and a net profit of 170 million yuan, up 35.5% [1] Financial Performance - Revenue for the first half of 2025 reached 1.46 billion yuan, reflecting a 28.2% year-on-year growth - Net profit was 170 million yuan, representing a 35.5% increase compared to the previous year - Gross margin improved to 49.3%, up 2.3 percentage points year-on-year - Cash and cash-equivalent assets amounted to 2 billion yuan, a 27.5% increase year-on-year - Operating cash flow for the first half was 410 million yuan, showing an 84.4% year-on-year growth [1] Business Segments - The company operates in three main business segments: Beauty and Health Services, Medical Beauty Services, and Sub-health Medical Services - Beauty and Health Services generated 810 million yuan in revenue, a 29.6% increase, with a gross margin of 42.1% [2] - Medical Beauty Services saw revenue rise to 500 million yuan, a 13.0% increase, with a gross margin of 56.9% [2] - Sub-health Medical Services experienced explosive growth, with revenue of 150 million yuan, up 107.8%, and a gross margin of 63.1% [2] Market Trends - Consumer demand is shifting towards emotional connections and spiritual resonance, with emotional value significantly influencing the younger generation's purchasing decisions - The emotional economy market in China is expected to reach 2.3 trillion yuan by 2025, indicating a potential for explosive growth [1] Store Network and Expansion - As of June 30, the company had a total of 522 stores, including 273 direct-operated and 279 franchised or managed stores - The company has a strong presence in first-tier cities, with 157 direct-operated stores in Beijing, Shanghai, Guangzhou, and Shenzhen, contributing over 60% of total revenue [3] Shareholder Return Plan - The company announced a shareholder return plan, committing to distribute at least 50% of annual net profit as dividends over the next three fiscal years, barring special circumstances - The first dividend payment of 0.52 HKD per share is scheduled for distribution by September 26 [3] Acquisition Strategy - The company has pursued rapid expansion through acquisitions, including a 70% stake in the second-largest beauty brand, Nairui'er, for 350 million yuan - Nairui'er generated revenue of 277 million yuan in the first half of 2025, with an adjusted net profit margin increasing from 6.5% to 10.4% post-acquisition [4][5] - The company aims to replicate the successful integration of Nairui'er to explore further industry consolidation opportunities [5]

Core Viewpoint - The company reported strong financial performance for the first half of 2025, with significant revenue and profit growth, showcasing the effectiveness of its business model and strategic initiatives [1][24]. Financial Performance - Revenue for the first half of 2025 reached 1.46 billion yuan, a year-on-year increase of 28.2% [1] - Net profit rose to 170 million yuan, reflecting a substantial growth of 35.5% year-on-year [1] - Adjusted net profit was 191 million yuan, up 37.8% year-on-year, with an adjusted net profit margin of 13.1%, marking a historical high [1] - Cash and cash-equivalent assets amounted to 2 billion yuan, a 27.5% increase year-on-year, with operating cash flow of 410 million yuan, up 84.4% year-on-year [1] Business Segments - The core beauty and health services generated 810 million yuan in revenue, a 29.6% increase year-on-year, with a gross margin of 42.1% [3] - Medical beauty services achieved revenue of 500 million yuan, a 13.0% increase year-on-year, with a gross margin of 56.9% [5] - The sub-brand for sub-health medical services saw explosive growth, with revenue of 150 million yuan, a 107.8% increase year-on-year, and a gross margin of 63.1% [8] Strategic Initiatives - The company has enhanced its digital marketing and multi-channel operations, with private domain operations contributing over 46% of new memberships [5] - The acquisition of a 90% stake in the brand Nairu has shown significant integration effects, with Nairu's revenue reaching 277 million yuan and an adjusted net profit margin increasing from 6.5% to 10.4% [11] - The opening of a flagship clinic in Guangzhou, covering nearly 5,000 square meters, aims to meet the deep health and wellness needs of customers in the Greater Bay Area [14] Shareholder Structure and Market Value - The company has optimized its shareholder structure, with new significant investors enhancing strategic development [18] - A capital market value enhancement plan has been proposed, including a commitment to distribute at least 50% of annual net profit as dividends over the next three fiscal years [18] - The company's market capitalization has increased by 90% year-to-date, reflecting strong market recognition of its value [18] Business Model - The company has developed a unique "dual beauty + dual health" business model, which integrates beauty and medical services to create a competitive advantage [20] - This model allows for efficient collaboration across business segments, maximizing long-term value for members and addressing high customer acquisition costs [21] - The average annual revenue per direct store has exceeded 10 million yuan, with medical beauty and sub-health services accounting for over 45% of total revenue [22]